Authors: PAPADIMITRIOU M PAPAGIANNI A DIAMANTOPOULOU D MITSOPOULOS E BELECHRI AM KOUKOUDIS P MEMMOS D

Citation: M. Papadimitriou et al., ACUTE-RENAL-FAILURE - WHICH TREATMENT MODALITY IS THE BEST, Renal failure, 20(5), 1998, pp. 651-661

Authors: MEMMOS D BELECHRI A VAKIANIS P VYZANTIADIS A PAPAIKOLAOU V LEONTSINI M ANTONIADIS A PAPADIMITRIOU M

Citation: D. Memmos et al., TOTAL PARATHYROIDECTOMY (PTX) WITH AUTOTRANSPLANTATION (ATP) INTO THEABDOMINAL ADIPOSE-TISSUE (AAT) - GRAFT FUNCTION AND RECURRENCE OF HYPERPARATHYROIDISM (HPTH), Journal of the American Society of Nephrology, 5(3), 1994, pp. 853-853

Authors: ALEXOPOULOS E VAKIANIS P KOKOLINA E KOUKOUDIS P SAKELLARIOU G MEMMOS D PAPADIMITRIOU M

Citation: E. Alexopoulos et al., ACUTE-RENAL-FAILURE IN A MEDICAL SETTING - CHANGING PATTERNS AND PROGNOSTIC FACTORS, Renal failure, 16(2), 1994, pp. 273-284

Authors: ALEXOPOULOS E SAKELLARIOU G MEMMOS D KARAMITSOS K LEONTSINI M PAPADIMITRIOU M

Citation: E. Alexopoulos et al., CYCLOPHOSPHAMIDE PROVIDES NO ADDITIONAL BENEFIT TO STEROID-THERAPY INTHE TREATMENT OF IDIOPATHIC MEMBRANOUS NEPHROPATHY, American journal of kidney diseases, 21(5), 1993, pp. 497-503

Authors: TSAKIRIS D VAKIANIS P KARAMITSOS K PAPADOPOULOU D MEMMOS D SAKELLARIOU G POLYMENIDIS A PAPADIMITRIOU M

Citation: D. Tsakiris et al., FOLLOW-UP OF CYTOTOXIC ANTIBODIES IN HEMODIALYSIS (HD) PATIENTS DURING A 5-YEARS PERIOD, Kidney international, 44(4), 1993, pp. 913-913